AGP Executive Report

Zambia–U.S. Health Deal Standoff: Attorney General Mulilo Kabesha says no MoU has been agreed yet on the proposed U.S. health assistance, and Zambia will hold public hearings once terms are final—after earlier court filings and public pushback over alleged “minerals-for-medicine” conditions. Research for Impact: The Ministry of Health is urging a shift from “research for knowledge” to “research for impact,” promising evidence to move findings into real patient care. National Health Policy Launch: Government has rolled out the 2026 National Health Policy and Implementation Plan, aiming for people-centred services and Universal Health Coverage. Funding Moves: Treasury released K17.8bn in April, including K6.6bn for the wage bill and K350m for drugs and medical supplies. People-First Health Reform: Civil society at the Africa Forward Summit is demanding community participation in health sovereignty talks, warning donor-driven agendas are sidelining patients.

Zambia–US Health Clash: Government says talks on a US-funded health deal stalled after Washington demanded citizens’ data access and linked the pact to a critical minerals arrangement—Zambia rejects both, citing privacy rights and concerns over “minerals-for-medicine” conditions. National Health Policy: In Lusaka, Health Minister Alex Katakwe launched the 2026 National Health Policy and Implementation Plan, promising equitable, affordable, people-centred care under Universal Health Coverage, while tackling HIV, TB, malaria and rising cancers and diabetes. Care in Climate Planning: A new push argues care services must be built into National Adaptation Plans and NDCs, warning climate shocks hit health systems and vulnerable groups hardest. TB Testing Breakthrough: A portable swab-based TB test (MiniDock MTB) is reported as fast and accurate, aiming to speed diagnosis where labs are scarce. Funding Moves: Treasury released K17.8bn in April, including K350m for drug and medical supplies procurement. Energy Push: Zambia accelerates clean power with major solar investments, including the Chisamba 100MW plant.

Over the last 12 hours, coverage touching health in Zambia is relatively limited, but several items stand out as part of a broader regional and policy environment. A key health-related story is a report on humid heat increasing the risk of preterm birth, alongside findings that low-dose aspirin could help reduce that risk (with a caution that pregnant women should consult a doctor before taking aspirin). Separately, a Zambia-focused health message appears in an article quoting a physician (Dr Aaron Mujajati) warning that erectile dysfunction can be a sign of underlying health problems—framing ED as a potential early indicator rather than an isolated issue. There is also a Zambia-specific development in training capacity: government commissioned the Clinic Skills Laboratory at Kaoma School of Nursing and Midwifery, described as a modern, safe setting for students and health professionals to practice clinical procedures.

The most prominent “health system” development in the last 12 hours is HIV prevention capacity-building on the Copperbelt. Ministry of Health workers in Ndola, Kitwe, and Chingola were trained on pre- and post-exposure prophylaxis (PrEP/PEP) delivered by CIDRZ with support from the U.S. Department of State, and the training is explicitly linked to readiness for the rollout of long-acting injectable HIV prevention (noted as Lenacapavir in the text). The same coverage also references Zambia’s early roll-out of long-acting injectable cabotegravir (CAB-LA) for HIV prevention, reinforcing continuity in HIV service strengthening.

Beyond direct clinical topics, the last 12 hours include a major political-health-adjacent theme: the ongoing diplomatic dispute around U.S. health assistance terms. While the most detailed evidence on the “minerals-for-health” dispute appears in older material, the last 12 hours include commentary and political framing around governance concerns raised by the outgoing U.S. ambassador Michael Gonzales, with Green Party leader Peter Sinkamba arguing that government responses have not addressed the substance of concerns—particularly in the health sector where audit-related accountability issues are referenced. In parallel, President Hichilema’s two-day visit to Mongu is reported to include commissioning a mini hospital and road infrastructure, positioning health investment within a wider development campaign.

In the 12 to 72 hours window, the dispute over U.S. health aid terms becomes much more explicit and is repeatedly corroborated: Zambia is described as accusing the U.S. of tying a $2 billion health deal to access to critical minerals, and of negotiating conditions involving sensitive data. This period also includes additional health-sector governance and legal coverage (e.g., LAZ urging repeal of a law making sexual offences non-bailable), and a water and sanitation intervention: the World Bank-supported ZWSSGC Programme for Results was launched with a stated goal of improving access to safe water and sanitation and reducing exposure to waterborne diseases. Taken together, the older material provides stronger evidence of a sustained policy conflict affecting health financing, while the most recent 12 hours show Zambia continuing to emphasize health workforce capacity and service delivery readiness.

Overall, the recent news mix suggests continuity in health system strengthening (training, skills labs, HIV prevention preparedness) alongside a persistent external-policy pressure point around how health aid is structured. However, the most recent 12-hour evidence is sparse on large, Zambia-specific health policy shifts beyond commissioning and training, so the clearest “major” development remains the longer-running U.S.–Zambia health-aid dispute, supported more heavily by coverage from 24 to 72 hours ago.

In the last 12 hours, Zambia’s health and governance news has been dominated by the escalating diplomatic dispute with the United States over a proposed health deal. Zambia’s foreign affairs minister Mulambo Haimbe is quoted accusing the outgoing U.S. ambassador of making “mischievous” and “undiplomatic” claims of corruption, and Zambia is also described as alleging that the U.S. is tying critical health assistance to access to Zambia’s mineral assets. The coverage frames the dispute as part of a broader “America First” approach that reshapes aid into transactional agreements, with concerns raised that Zambia may be asked to share sensitive health data in return for support.

Alongside the diplomacy, there are also health-system capacity and service-delivery items. Copperbelt health workers are reported to have commended the U.S. Department of State and CIDRZ for strengthening HIV prevention capacity, following training on pre- and post-exposure prophylaxis (PrEP/PEP) delivered by CIDRZ with U.S. support. The training is described as preparing for the rollout of long-acting injectable HIV prevention (Lenacapavir is mentioned in the text), with participants encouraged to keep engaging with new information to maintain responsive service delivery.

The last 12 hours also include routine but notable public-safety and health-sector developments. Police are investigating the deaths of two children in separate cases in Nchelenge and Chibombo districts, with one case involving alleged assault and the other involving a missing child later reported as murdered. Separately, Zambia’s Ministry of Health is reported to have commissioned a Clinic Skills Laboratory at Kaoma School of Nursing and Midwifery, intended to provide a modern, safe training environment for clinical procedures and improve nursing and midwifery education outcomes.

Looking beyond the most recent window, the broader 7-day coverage shows continuity in the Zambia–U.S. fallout narrative, with multiple reports repeating that Zambia is pushing back on terms that link health funding to minerals access and/or data-sharing demands. There is also supporting context on the wider regional and global policy environment around health and data—such as calls for governance and regulation of AI in health care and discussions of how international partnerships can affect health systems—though these are not Zambia-specific in the provided excerpts.

Overall, the most significant thread in the evidence is the Zambia–U.S. dispute over the health deal’s conditions, which is repeatedly tied to minerals access and sensitive data concerns. By contrast, the other Zambia health items in the last 12 hours (HIV prevention training, skills-lab commissioning, and child-death investigations) read more like implementation and public-safety coverage rather than a single major new policy shift.